Chris Lau
Chris Lau (RSS)
InvestorPlace Contributor

Read complete bio
Recent Articles

Is Ambarella, Inc. All Hype or Is Its CV Chip All That?

Apr. 20, 2018, 12:55 pm EDT – Ambarella stock is stuck in a range until the company releases its CV1 chip to the market, which it is planning for later this year. As AMBA targets the security camera market and autonomous driving, revenue from chip sales could jump. More 

Dropbox, Inc. Stock Set to Rocket Higher Even After a Successful IPO

Apr. 19, 2018, 1:28 pm EDT – DBX may look like an expensive, hyped technology stock, but its user growth is very real. Though risky, the odds of Dropbox disappointing investors are low. More 

Lam Research Corporation Prepped for Growth Into Earnings

Apr. 17, 2018, 12:18 pm EDT – Lam Research stock will likely report another blowout quarter, thanks to strong demand for LRCX's chips for memory and storage. More 

AbbVie Inc. Is a Clear Value Play in Biotech Stocks

Apr. 17, 2018, 11:59 am EDT – AbbVie stock is not bouncing back after investors bailed on it following potentially negative clinical results. For value investors, ABBV trades at a discount to its peers but investors seem skittish of biotech's risks. When that changes, ABBV stock will be one of the first to recover. More 

Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet

Apr. 13, 2018, 11:35 am EDT – Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock. More 

Why Delta Air Lines, Inc. Stock Is Undervalued by 55 Percent

Apr. 12, 2018, 8:13 am EDT – Despite low valuations on the stock market that would attract value investors, Delta Air Lines, Inc. (NYSE:DAL) is stuck in a downtrend in 2018. Delta stock trades at a P/E of 10 times and forward price-earnings multiples are even lower at around seven times. Persistently rising oil prices would bring ominously lower profits, if not... More 

A Big Bet on Gene Therapy Is Just What Novartis AG (ADR) Stock Needs

Apr. 12, 2018, 7:43 am EDT – Novartis put its excess cash to good use by broadening its business into the gene therapy market. Competition could prove tough for NVS stock, but Novartis is ready for the challenge ahead. More 

Why Advanced Micro Devices, Inc.’s New APU Chip Matters

Apr. 9, 2018, 11:08 am EDT – Advanced Micro Devices stock trades as though it has no potential to take market share from Intel. But the market is wrong on this call. Advanced Micro cut the price of its powerful advanced processing unit named Ryzen, a significant move for AMD. More 

Exact Sciences Corporation Could Break Out Despite Steep Drop in Biotech

Apr. 9, 2018, 5:31 am EDT – Exact Sciences is a rapidly growing biotech firm whose decline looks overdone. Seasonal strength in the second quarter could renew bullish sentiment in EXAS stock. More 

Micron Technology, Inc. Stock Won’t See $60 Highs Again for Awhile

Apr. 6, 2018, 9:40 am EDT – Shortly after reporting incredibly strong quarterly results and issuing a great outlook, shares of Micron Technology Inc. (NASDAQ: MU) topped out at around $60 a share, only to fall gradually. If the company reported a strong quarter and business is getting better, why is Micron stock not above $60? More important, when will the stock... More